Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models

Ran Wei, Limin Mao, Ping Xu, Xinghai Zheng, Robert M Hackman, Gerardo G. MacKenzie, Yuefei Wang

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Fingerprint

Dive into the research topics of 'Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences